Explore evidence

3 %VIA positivity was 3% among the general population.

Nigeriacancer du col de l'utérusobserved 2021published 2023BMC public healthPubMeddocument of 12 observations

33.3 %Among 339 adult patients managed for chronic conditions in Yenagoa, Bayelsa State, Nigeria, 113 (33.3%) forfeited necessities as a coping strategy for healthcare costs.

Nigeriachronic diseasespublished 2025West African journal of medicinePubMeddocument of 8 observations

14 daysViral clearance of MPXV appeared to be relatively rapid, with most samples being MPXV-negative within 14 days.

NigeriampoxHAL · Unilimdocument of 102 observations

81.5 %The pooled specificity of malaria rapid diagnostic tests (RDTs) in Nigeria was 81.5%.

Nigeriapaludismepublished 2025Malaria journalPubMeddocument of 2 observations

0.61 inoculations/person/nightEntomological inoculation rate of Anopheles mosquitoes was 0.61 in Kargo.

Nigeriapaludismepublished 2023Parasitology researchPubMeddocument of 8 observations

88.89 %88.89% of sickle cell anaemia patients screened using Natriuretic peptide were at risk of developing pulmonary hypertension (NT-proBNP levels ≥ 160 pg/ml).

Nigeriadrépanocytosepublished 2022West African journal of medicinePubMeddocument of 8 observations

14.5 %Twenty-five (14.5%) patients had severe disease.

NigeriaCOVID-19observed 2020published 2020West African journal of medicinePubMeddocument of 8 observations

25.6 %The second most common indication for treatment was diabetic macular edema (DME) in 10 eyes (25.6%).

Nigeriadiabetic macular edemapublished 2025Journal francais d'ophtalmologiePubMeddocument of 8 observations

4 %Among enrolled participants, 1 (4%) had a PHQ-9 score ≥17.

Nigeriadépressionpublished 2025JMIR research protocolsPubMeddocument of 4 observations

25.6 %Only 25.6% of study participants knew about the positive role of community engagement and education in reducing the prevalence of sickle cell disease and alleviating sickle cell disease crises.

Nigeriadrépanocytosepublished 2023Frontiers in geneticseurope_pmcdocument of 5 observationsDOI 10.3389/fgene.2023.1052444

Les projets de démonstration de l’efficacité et de la performance de l’IVA pour le dépistage du cancer du col utérin montrent des résultats concluants à Madagascar, au Malawi, au Nigéria, en Ouganda, en Tanzanie et en Zambie en 2009.

Madagascar · Malawi · Nigeria · Ouganda · Tanzaniecancer du col de l'utérusobserved 2009HAL · Unilimdocument of 81 observations

1.2 %The prevalence of HIV/TB coinfection in Cross River State, Nigeria was 1.2%.

NigeriaHIV/TB coinfectionpublished 2020Journal of immunoassay & immunochemistryPubMeddocument of 19 observations

25.3 %Among 641 participants in Lagos state, Nigeria, 162 (25.3%) were living with HIV.

NigeriaVIH/sidaobserved June 2021 to June 2024published 2026PloS onePubMeddocument of 12 observations

100 %The sensitivity and specificity for SS, SC, AS, AC, and AA genotypes by HemotypeSC relative to PCR were each 100%.

Nigeriadrépanocytosepublished 2021Global pediatric healtheurope_pmcdocument of 5 observations

17 %The prevalence of placental parasitaemia in the NC group was 17%.

Nigeriapaludismepublished 2007Malaria journaleurope_pmcdocument of 6 observationsDOI 10.1186/1475-2875-6-88

1,600,000 deathsOver 1.6 million Nigerians have succumbed to AIDS since its discovery.

NigeriaVIH/sidapublished 2024Annals of African medicinePubMeddocument of 12 observations

68 patientsSixty-eight children aged 5–17 years (mean age 10.6 ± 0.4 years; 56% male) were randomized in a double-blind RCT of oral L-arginine-hydrochloride for sickle cell anemia vaso-occlusive painful crisis in Nigeria.

Nigeriasickle cell anemia vaso-occlusive painful crisispublished 2021American journal of hematologyPubMeddocument of 5 observations

49.9 %Among 607 patients diagnosed with breast cancer in Nigeria between January 2010 and December 2018, surgery was performed on 49.9% (303/607) of patients.

Nigeriacancer du seinobserved 2010–2018published 2021International journal of cancerPubMeddocument of 12 observations

28.8 %The I431V mutation was found in 19 of 66 pretreatment pfdhps sequences, representing 28.8%.

Nigeriapaludismepublished 2021Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument of 5 observations

15.4 %HIV prevalence was 15.4%–23.9% at highway settlements in Nigeria.

NigeriaVIH/sidaobserved 2009-12published 2016PloS onePubMeddocument of 14 observations

Patients with HIV on HAART have thicker optic nerves compared with the general population in Kano, Nigeria.

NigeriaVIH/sidaobserved October 2017 to June 2018published 2019Nigerian journal of clinical practicePubMeddocument of 5 observations

75 %The cure rate for pyrimethamine-sulfadoxine was 75.0% on day 28.

Nigeriapaludismeobserved day 28published 2004Clinical drug investigationeurope_pmcdocument of 13 observations

4.1 μg/mLFraction IMD of I. senegalensis leaves extract exhibited an IC50 of 4.1 ± 0.1 μg/mL against Plasmodium falciparum 7G8 strain (chloroquine-resistant).

NigeriapaludismeHAL · Unilimdocument of 39 observations

96 %The triple mutant haplotype (S108N+N51I+C59N) was present in 96.0% of Plasmodium falciparum isolates from children with haemoglobin AA.

Nigeriapaludismepublished 2021West African journal of medicinePubMeddocument of 3 observations

All tick samples were negative for African swine fever virus (ASFV) DNA.

NigeriaAfrican swine fever virus (ASFV)published 2025Pathogens (Basel, Switzerland)europe_pmcdocument of 5 observations